Study of two different treatment plans of demcizumab or placebo in combination with standard chemotherapy in non-squamous non-small cell lung cancer

Registry ID

EUCTR2014-003356-30

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

OncoMed Pharmaceuticals, Inc.

Start date

2014-11-19

Completion date

2017-07-04

Last update

2026-08-16

Conditions

• Non-Squamous Non-Small Cell Lung Cancer

Summary

To compare the efficacy of Arm 1 to Arm 2 and Arm 1 to Arm 3 in subjects with 1st-line stage IV non-squamous non-small cell lung cancer

Locations

• , , Spain
• , , Italy
• , , Belgium
• , , Germany

Related clinical trials

• A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
• A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer

View on source registry